SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sonus Pharma (SNUS) ? Opinions -- Ignore unavailable to you. Want to Upgrade?


To: David S. who wrote (267)3/20/1998 3:18:00 PM
From: (no name provided)  Respond to of 384
 
Daiichi signed with Nycomed for its ultrasound contrast agent.

Just found this on DowJones newswire:

"Nycomed Amersham plc today announced the Daiichi Pharmaceutical
Company of Japan has exercised its option to market Nycomed Amersham's
ultrasound contrast agent, NC100100, in Japan."

Remember who SNUS' partner in Japan is?

Right, Daiichi.

Go figure....

Kafka666